ArticleCancer communications (London, England)2019

Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification.

Zhi-Xia Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.